Loading…
Turn Therapeutics Inc. is projected to rise to $8.01 by 2027, a +51% move from its current price of $5.29. TTRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.07 | $5.29 | $5.52 | +0.08% |
| May 30 | $4.99 | $5.30 | $5.63 | +0.16% |
| May 31 | $4.93 | $5.30 | $5.71 | +0.24% |
| Jun 1 | $4.88 | $5.31 | $5.78 | +0.32% |
| Jun 2 | $4.83 | $5.31 | $5.84 | +0.40% |
| Jun 3 | $4.79 | $5.32 | $5.90 | +0.48% |
| Jun 4 | $4.76 | $5.32 | $5.95 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.76 | $5.32 | $5.95 | +0.56% |
| Week 2 | $4.57 | $5.35 | $6.27 | +1.13% |
| Week 3 | $4.43 | $5.38 | $6.53 | +1.70% |
| Week 4 | $4.32 | $5.41 | $6.77 | +2.28% |
| Week 5 | $4.23 | $5.44 | $6.99 | +2.85% |
| Week 6 | $4.16 | $5.47 | $7.20 | +3.43% |
| Week 7 | $4.09 | $5.50 | $7.40 | +4.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Turn Therapeutics Inc. is a healthcare company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.
The company was formerly known as Global Health Solutions, Inc and changed its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Turn Therapeutics Inc. trades under the ticker symbol TTRX in the Healthcare sector. The current price is $5.13.
Its market capitalization is $152.81M and it ranks 4014 by market cap.
A major floor 49.8% below — a decisive break under it would weaken the trend.
The nearest floor, 36.7% below — buyers have tended to step in here.
Price is pressing into resistance (1.3% away) — a breakout level to watch.
A major ceiling 26.2% above — clearing it would confirm fresh momentum.
Key TTRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TTRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.10 | Buy | $5.09 | Buy |
| MA 10 | $4.70 | Buy | $4.79 | Buy |
| MA 20 | $4.24 | Buy | $4.41 | Buy |
| MA 50 | $3.74 | Buy | $3.99 | Buy |
| MA 100 | $3.87 | Buy | $4.01 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 77.12 | Sell |
| Stoch RSI (14) | 67.33 | Neutral |
| CCI (20) | 132.42 | Buy |
| Williams %R (14) | -4.46 | Info |
| MACD (12,26,9) | 0.13 | Buy |
| ROC (12) | 39.58 | Buy |
| Bollinger %B (20,2) | 0.95 | Neutral |
| Stochastic %K (14) | 95.54 | Sell |
| TRIX (15) | 1.16 | Buy |
| Awesome (5,34) | 1.19 | Buy |
| Ultimate (7,14,28) | 79.90 | Sell |
| Momentum (10) | 1.31 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 5.43 | Sell |
| ADX (14) | 34.18 | Buy |
| ATR (14) | 0.15 | Info |
The sentiment is NEUTRAL. RSI14 is 80, and the 50-day simple moving average (SMA50) is $3.67. The stock shows a 30-day price range from $3.84 to $6.86, with key support at $3.32 and resistance at $5.13.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.12 | $5.29 | $7.82 | 0% | Neutral | |
| $5.53 | $8.01 | $12.57 | +51% | Bullish | |
| $5.14 | $8.01 | $13.48 | +52% | Bullish | |
| $4.85 | $8.06 | $14.31 | +52% | Bullish | |
| $4.83 | $8.53 | $15.82 | +61% | Bullish | |
| $4.34 | $8.11 | $15.62 | +53% | Bullish | |
| $4.86 | $9.62 | $19.16 | +82% | Bullish | |
| $5.68 | $11.85 | $24.33 | +124% | Bullish | |
| $5.92 | $13.04 | $27.51 | +146% | Bullish | |
| $6.49 | $14.42 | $31.21 | +173% | Bullish | |
| $9.60 | $21.33 | $49.05 | +303% | Bullish | |
| $13.48 | $29.95 | $68.90 | +466% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.12 | $5.29 | $6.37 | +0.00% |
| June 2026 | $4.73 | $5.72 | $7.20 | +8.17% |
| July 2026 | $4.61 | $5.69 | $7.38 | -0.52% |
| August 2026 | $4.36 | $5.47 | $7.26 | -3.85% |
| September 2026 | $4.42 | $5.61 | $7.58 | +2.53% |
| October 2026 | $4.45 | $5.73 | $7.87 | +2.14% |
| November 2026 | $4.24 | $5.52 | $7.68 | -3.77% |
| December 2026 | $4.22 | $5.54 | $7.82 | +0.50% |
Click any year to see its month-by-month TTRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TTRX is projected to trade between $3.12 and $7.82, averaging $5.29 — a potential gain of 0% from today's $5.29. A consolidation phase looks the most probable path here.
Turn Therapeutics Inc.'s 2027 outlook centres on $8.01, within a $5.53 to $12.57 range. That is up +51% on the projected 2026 average. That marks a +51% change versus current levels. Momentum favours further upside here.
By 2028, TTRX could reach as high as $13.48, with a base case around $8.01 and support toward $5.14 — roughly +52% from $5.29. Buyers look set to stay in control over this stretch.
Expect TTRX to range from $4.85 to $14.31 through 2029. The $8.06 average target implies a +52% move from current prices. That is up +1% on the projected 2028 average. Momentum favours further upside here.
The TTRX price prediction for 2030 points to an average of $8.53 (low $4.83, high $15.82) — a potential gain of +61% on today's $5.29. Buyers look set to stay in control over this stretch.
In 2031, TTRX is projected to trade between $4.34 and $15.62, averaging $8.11 — a potential gain of +53% from today's $5.29. That is -5% versus the projected 2030 average. Momentum favours further upside here.
Turn Therapeutics Inc.'s 2032 outlook centres on $9.62, within a $4.86 to $19.16 range. That is up +19% on the projected 2031 average. That marks a +82% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, TTRX could reach as high as $24.33, with a base case around $11.85 and support toward $5.68 — roughly +124% from $5.29. Momentum favours further upside here.
Expect TTRX to range from $5.92 to $27.51 through 2034. The $13.04 average target implies a +146% move from current prices. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The TTRX price prediction for 2035 points to an average of $14.42 (low $6.49, high $31.21) — a potential gain of +173% on today's $5.29. Momentum favours further upside here.
In 2040, TTRX is projected to trade between $9.60 and $49.05, averaging $21.33 — a potential gain of +303% from today's $5.29. That is up +48% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Turn Therapeutics Inc.'s 2050 outlook centres on $29.95, within a $13.48 to $68.90 range. That is up +40% on the projected 2040 average. That marks a +466% change versus current levels. Momentum favours further upside here.
Investing $1,000 in TTRX today (≈ 189.035917 TTRX) could be worth
$5,662.49
+$4,662.49 (+466%) by 2050 · US Dollar
Based on the average projected TTRX price of $29.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TTRXwould be worth at today's price.
$1,000 invested in TTRX on Oct 8, 2025 (≈ 142.857143 TTRX) would be worth
$755.71
-$244.29 (-24.4%) today · 0.76× · US Dollar
Based on a TTRX entry price of $7 vs. today's $5.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.76 | $1,111.34 | +11.1% |
| 1 month ago | $3.7 | $1,429.73 | +43.0% |
| 3 months ago | $3.84 | $1,377.6 | +37.8% |
| 6 months ago | $3.52 | $1,502.84 | +50.3% |
| All time ago | $7 | $755.71 | -24.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TTRX forecast.
Our base-case forecast reaches $11.00 around 2033.
Implied market cap at $11.00: $327.67M
The multi-year forecast points to a bullish trajectory from 2027 onward. The 2026 forecast shows min $3.12, avg $5.13, max $7.64 with ROI 0 and Neutral sentiment. From 2027 onward, the averages rise to $7.80 (2027), $8.14 (2030), $19.35 (2040), and $27.21 (2050), with corresponding ROIs of 52.1, 58.6, 277.2, and 430.4 respectively, and sustained bullish sentiment.
Specifically, the model projects 2030 avg $8.14 and max $15.32 with ROI 58.6, 2040 avg $19.35 and max $44.51 with ROI 277.2, and 2050 avg $27.21 and max $62.58 with ROI 430.4. These figures illustrate a long-run growth path, albeit with the inherent uncertainty of price forecasts.
Tap a question to reveal the answer.
Avg $8.14, min $4.50, max $15.32, ROI 58.6, sentiment BULLISH.
Forecasts show a bullish sentiment from 2027 onward with rising averages and ROIs, including 2027 avg $7.80 and ROI 52.1, 2030 avg $8.14 and ROI 58.6, and 2050 avg $27.21 with ROI 430.4. These are estimates, not guarantees.
Yes, the forecast includes a 2040 max of $44.51 and a 2033 max of $23.03, with 2040 avg $19.35, indicating a path that could exceed $20 under the model’s projections.
Current price is $5.13 and market cap is $152.81M.
The 30-day range is $3.84 to $6.86.
Turn Therapeutics Inc. Community Discussion
0Share your Turn Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.